TY  - JOUR
AU  - Lopez-Perez, David
AU  - Redruello-Romero, Anaïs
AU  - Garcia-Rubio, Jesus
AU  - Arana, Carlos
AU  - Garcia-Escudero, Luis A
AU  - Tamayo, Francisco
AU  - Salmeron, Javier
AU  - Galvez, Julio
AU  - Leon, Josefa
AU  - Carazo, Angel
PY  - 2022
DO  - 10.3389/fendo.2022.818388
SN  - 1664-2392
UR  - http://hdl.handle.net/10668/20558
T2  - Frontiers in endocrinology
AB  - The paradigm of mast cells in type 2 diabetes is changing. Although they were first considered deleterious inflammatory cells, now they seem to be important players driving adipose tissue homeostasis. Here we have employed a flow cytometry-based...
LA  - en
PB  - Frontiers Research Foundation
KW  - adipose tissue
KW  - bariatric surgery
KW  - flow cytometry
KW  - mast cell
KW  - obesity
KW  - type 2 diabetes
KW  - Adipose Tissue
KW  - Diabetes Mellitus, Type 2
KW  - Humans
KW  - Leukocyte Common Antigens
KW  - Mast Cells
KW  - Obesity, Morbid
KW  - Phosphoric Diester Hydrolases
KW  - Proto-Oncogene Proteins c-kit
KW  - Pyrophosphatases
KW  - Receptors, IgE
TI  - In Obese Patients With Type 2 Diabetes, Mast Cells in Omental Adipose Tissue Decrease the Surface Expression of CD45, CD117, CD203c, and FcϵRI.
TY  - research article
VL  - 13
ER  -